Lupin Shares Slump 2% on Receiving 5 Observations from USFDA
Shares of Lupin Ltd were trading in the red and 2% lower on 7 October after the company announced receiving 5 observations from the USFDA. ...
Tag : USFDA observations
Aurobindo Pharma Shares Drop 2.5% After USFDA Issues 10 Observations to Telangana API Unit
Shares of Aurobindo Pharma Ltd. fell by 2.5% after reaching a day’s high of Rs 1,518.90 on 30th September, following the company’s announcement that the...
Lupin Shares Slump 1% as Pithampur Facility Receives 3 Observations
Shares of Lupin Ltd were trading in the red and 1.75% lower on 30 September after the company announced that its Pithampur facility in Madhya...
Granules India Shares Fall 8% on 6 USFDA Observations
Shares of Granules India Ltd. fell 8% after reaching a day’s high of Rs 690 on 12th September, following six USFDA observations issued to the...
Gland Pharma Shares Slip 2% as USFDA Issued 2 Observations
Shares of Gland Pharma Ltd slipped 2% and hit an intra-day low of Rs 1,978.40 on 25 July after the company announced that the US...
Zydus Lifesciences Shares Slump 5% as Unit Receives Ten Observations
Shares of Zydus Lifesciences were trading in the red and 5% lower on 24 April after the company’s injectables production plant received ten observations from...
Aurobindo Pharma Shares Slump 1% as Arm Receives 3 Observations
Shares of Aurobindo Pharma Ltd were trading in the red and 1.5% lower on 8 April after the company announced receiving three observations from USFDA....
Cipla Shares Traded 1.51% Lower on Inspection by USFDA
Shares of Cipla Ltd. sank 1.51% on a routine current Good Manufacturing Practices (cGMP) inspection conducted by the United States Food and Drug Administration (USFDA)...
Alembic Pharma Shares Slip 2% on Receiving 4 Observation from USFDA
Shares of Alembic Pharmaceuticals Ltd slumped 2% on 11 March after the USFDA issued a Form 483 with 4 observations from its Gujarat plant. In...
Marksans Pharma Shares Rally 7% Over US FDA Inspection Report with Zero Observations
Shares of Marksans Pharma gained more than 7% in trade on Friday after the company announced that its subsidiary received the Establishment Inspection Report from...